Theracos IPO

theracos.com

Theracos develops, acquires, and supports research programs in inflammation, metabolism, and depression through research activities throughout the world and establishes the clinical efficacy of its therapeutic candidates through multicenter international trials

Founded2000
Total Funding to Date$135.86MM
Register for Details

For more details on financing and valuation for Theracos, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Theracos Ticker Symbol

Theracos does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Theracos Stock Price

The stock price for Theracos will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Theracos Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/20/2013 Series C $93.09MM raised $XXX.XX $XXX.XX
3/29/2011 Series B $40MM raised $XXX.XX $XXX.XX
6/4/2002 Series A $2.77MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Theracos in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector